fda lawsuit tirzepatide news FDA's tirzepatide decision creates uncertainty for patients—and leads to a Fake Weight Loss Drugs: What

Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors for metabolic and obesity research.

This positioning flexibility supports broader distribution opportunities across eCommerce, practitioner channels, affiliate marketing networks, subscription programs, and retail wellness environments

According to the 2025-2030 Dietary Guidelines for Americans, which favor protein over fiber-rich foods, only 5% of Americans get enough fiber for gut health and longevity, Nextdia fiber supplement is the easy gentle solution for every day

This retrospective, observational study assessed persistence and adherence in patients with type 2 diabetes (T2D) initiating once-weekly or daily injectable glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in US clinical practice

We compared these mechanisms in western diet (WD)-fed melanocortin 4 receptor knockout (MC4R-KO) mice, a human MASH pathology model